SAB Biotherapeutics (SABS) Return on Assets (ROA) (2021 - 2026)
SAB Biotherapeutics (SABS) Return on Assets (ROA) from Mar 31, 2021 to Mar 31, 2026. The TTM SAB Biotherapeutics (SABS) Return on Assets (ROA) is -7.59%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROA
Quarterly ROA
Annual Return on Assets (ROA) change of SAB Biotherapeutics (SABS)
| Year | Return on Assets (ROA) | Change |
|---|---|---|
| 2025 | 7.68% | -109.95% |
| 2024 | -77.17% | +53.54% |
| 2023 | -50.26% | +36.52% |
| 2022 | -36.82% | +70.49% |
| 2021 | -21.60% | N/A |
| 2021 | -21.60% | +121998.48% |
| 2020 | -0.02% | -100.05% |
| 2020 | 35.59% | N/A |